header

Designand synthesis of novel pyridopyrimidine derivatives of anticipated anti-cancer activity / (Record no. 83904)

MARC details
000 -LEADER
fixed length control field 03354cam a2200349 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field EG-GiCUC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250223032910.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220109s2021 ua d f m 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-GiCUC
Language of cataloging eng
Transcribing agency EG-GiCUC
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
049 ## - LOCAL HOLDINGS (OCLC)
Holding library Deposite
097 ## - Thesis Degree
Thesis Level Ph.D
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Cai01.08.05.Ph.D.2021.Kh.D
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Kholoud Fouad Aljamal
245 10 - TITLE STATEMENT
Title Designand synthesis of novel pyridopyrimidine derivatives of anticipated anti-cancer activity /
Statement of responsibility, etc. Kholoud Fouad Aljamal ; Supervised Amal Abdelhaleem Eissa , Heba Abdelrasheed Allam , Hany Said Ibrahim
246 15 - VARYING FORM OF TITLE
Title proper/short title تصميم وتشييد مشتقات البيريدوبيريميدين الجديدة المتوقع لها فعالية كمضادات للسرطان
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Cairo :
Name of publisher, distributor, etc. Kholoud Fouad Aljamal ,
Date of publication, distribution, etc. 2021
300 ## - PHYSICAL DESCRIPTION
Extent 145 P. :
Other physical details charts ;
Dimensions 25cm
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry
520 ## - SUMMARY, ETC.
Summary, etc. Cancers are a large family of diseases that involve abnormal cell growth with the potential to invade or spread to other parts of the body. Cancer is the second cause of mortality after cardiac diseases in the world. It is continuing to act as a major problem of health in both developing and developed countries. Accordingly, the search for new anticancer agents is extremely desirable to improve survival rates and minimize toxicities and drug resistance.Many researchers reported the importance of pyrido[2,3-d]pyrimidine as an interesting bioactive scaffold implicated in the development of anticancer agents. Also, literature survey highlighted the apoptotic activity of certain pyrido[2,3-d]pyrimidines leading to their anticancer effect. Accordingly, this research focused on the synthesis of novel pyrido[2,3-d]pyrimidines hoping to obtain promising anticancer agents with fewer side effects.The present investigation deals with the synthesis of bicyclic derivatives, namely: (4-substituted phenyl)pyrido[2,3-d] pyrimidin-4-amine IVa-h, 7-(4-methoxyphenyl)-4-(phenylamino)5-(4-substituted phenyl)pyrido[2,3-d] pyrimidin-2(1H)-thione Va-d, 1-(7-(4-methoxyphenyl)-3-phenyl-5-(4-substituted phenyl)-2-thioxo-2,3-dihydro pyrido[2,3-d]pyrimidin-4-yl)-3-phenyl thiourea VIa-d, 5-(4-(methylthio) phenyl)-7-(4-(un)substitute dphenyl)-2-thioxo-2,3-dihydropyrido[2,3-d] pyrimidin-4(1H)-one VIIa-d, 2-hydrazinyl-5-(4-(methylthio) phenyl)-7-(4-(un)substituted phenyl)pyrido [2,3-d]pyrimidin-4(3H)-one VIIIa,b, in addition to tricyclic derivatives: 3-amino-6-(4-(methylthio)phenyl)-8-(4-(un)substituted phenyl)-pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-one IXa,b ,6-(4-(methyl thio)phenyl)- vii 8-(4-(un)substituted phenyl)-3-thioxo-2,3-dihydropyrido[2,3-d][1,2,4] triazolo[4,3-a]pyrimidin-5(1H)-one Xa,b. Compounds IVa-h, Va-d, VIa-d, VIIa-d and VIIIa,b were evaluated for their anticancer activity as EGFR inhibitors, using Gefitinib as a reference compound
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Issued also as CD
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Anti-cancer activity
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Pyridopyrimidine
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Pyrimidines
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Amal Abdelhaleem Eissa ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Hany Said Ibrahim ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Heba Abdelrasheed Allam ,
Relator term
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a>
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Nazla
Reviser Revisor
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Shimaa
Reviser Cataloger
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
Holdings
Source of classification or shelving scheme Not for loan Home library Current library Date acquired Full call number Barcode Date last seen Koha item type Copy number
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة قاعة الرسائل الجامعية - الدور الاول 11.02.2024 Cai01.08.05.Ph.D.2021.Kh.D 01010110085226000 22.09.2023 Thesis  
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة مخـــزن الرســائل الجـــامعية - البدروم 11.02.2024 Cai01.08.05.Ph.D.2021.Kh.D 01020110085226000 22.09.2023 CD - Rom 85226.CD